Loading...
stem cell clinical trials
Stem Cell News: Clinical Trials
Repairing Cleft Palate with Dental Pulp Stem Cells (DPSCs)

This Phase II clinical trial evaluates the safety and efficacy of deciduous dental pulp stem cells (DPSCs) for repairing alveolar clefts in children with cleft lip and palate.

Read more »
Treating Acute Ischemic Stroke with Dental Pulp Stem Cells (DPSCs)

This randomized Phase I/II clinical trial evaluates the safety and efficacy of allogeneic dental pulp stem cells (DPSCs) for treating patients with acute ischemic stroke.

Read more »
Treating Type 2 Diabetes with Dental Pulp Stem Cells (DPSCs)

This Phase I/II clinical study evaluates the safety and therapeutic potential of dental pulp stem cells (DPSCs) for improving glucose control and pancreatic function in patients with type 2 diabetes.

Read more »
Treating Type 1 Diabetes with Dental Pulp Stem Cells (DPSCs)

This clinical trial evaluates the safety and efficacy of dental pulp stem cells (DPSCs) for improving pancreatic islet function and glycemic control in diabetic patients with significantly reduced islet function.

Read more »
Osteoarthritis Treatment Utilizing Dental Pulp Stem Cells (DPSCs)

This Early Phase I clinical trial evaluates the safety and efficacy of dental pulp stem cells (DPSCs) for treating patients with primary mild to moderate knee osteoarthritis.

Read more »
Chronic Periodontitis Treatment With Dental Pulp Stem Cells (DPSCs) Enters Phase II Clinical Trials

This Phase II clinical trial evaluates the safety and efficacy of human dental pulp stem cells for regenerating periodontal tissue in patients with chronic periodontitis.

Read more »
Treating Depression with Dental Pulp Stem Cells (DPSCs)

This Phase I/II clinical trial evaluates the safety and efficacy of dental pulp stem cells (DPSCs) as a regenerative therapy for patients with depression.

Read more »
Huntington's Disease Treatment With Dental Pulp Stem Cells (DPSCs) Moves to Phase III Clinical Trials

This Phase III clinical trial evaluates the safety and efficacy of human dental pulp stem cells as a regenerative therapy for patients with Huntington's disease.

Read more »
877-783-6728877-783-6728 ENROLL NOW